PER 15.0% 11.5¢ percheron therapeutics limited

Future Cancer Treatment, page-4

  1. 3,335 Posts.
    lightbulb Created with Sketch. 165
    One would hope there were two bidders then the long term may get value for their asset. I hope 1103 results are good enough for ISIS to report the successful trial, then we may see some buying action from around the world. I also hope the last 18 trial subjects were of low weight and high sIGF-1 levels. I'm also wondering if the trial of the latter 18 had to be split equally between 200mg once per week and 200mg twice per week.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.